Helper-free HSV-1 amplicons elicit a markedly less robust innate immune response in the CNS.
Helper-free HSV-1 amplicons elicit a markedly less robust innate immune response in the CNS.
复制标题
无辅助 HSV-1 扩增子在中枢神经系统中引发的先天免疫反应明显较差。
DOI:
10.1016/s1525-0016(02)00036-9
复制
发表时间:
2003
期刊:
影响因子:
--
通讯作者:
Federoff,HowardJ
中科院分区:
文献类型:
--
作者:
Olschowka,JohnA;Bowers,WilliamJ;Hurley,SeanD;Mastrangelo,MichaelA;Federoff,HowardJ
The development and implementation of direct gene transfer technologies for the study and treatment of chronic CNS disorders inherently requires consideration of vector safety. Virus-based vectors represent the most efficient modalities but harbor the potential to induce vigorous innate and adaptive immune responses when administeredin vivo.These responses can arise because of virus particle components, resultant viral gene expression, and/or transgene expression. In the current study, we describe the innate responses elicited upon stereotactic delivery of herpes simplex virus type 1-based amplicon vectors. C57BL/6 mice were injected with sterile saline, β-galactosidase-expressing amplicon (HSVlac) packaged by a conventional helper virus-based technique, or helper virus-free HSVlac. After killing the mice at either 1 or 5 days after transduction, we analyzed them by immunocytochemistry and quantitative RT-PCR for various chemokine, cytokine, and adhesion molecule gene transcripts. All injections induced inflammation, with blood/brain barrier opening on day 1 that was enhanced with both amplicon preparations as compared with saline controls. By day 5, mRNA levels for the pro-inflammatory cytokines (IL-1β, TNF-α, IFN-γ), chemokines (MCP-1, IP-10), and an adhesion molecule (ICAM-1) had returned to baseline in saline-injected mice and to near-baseline levels in helper virus-free amplicon groups. In contrast, mice injected with helper virus-packaged amplicon stocks elicited elevated inflammatory molecule expression and immune cell infiltration even at day 5. In aggregate, we demonstrate that helper virus-free amplicon preparations exhibit a safer innate immune response profile, presumably as a result of the absence of helper virus gene expression, and provide support for future amplicon-based CNS gene transfer strategies.